Project

Description

Our project focuses on prime editing, which has revolutionized the gene editing landscape. It is advantageous over current gene editing technologies such as the CRISPR system, as it allows for more precise edits, lowering the likelihood of off-target effects.

The Importance of Gene Editing

In recent years, there has been a remarkable surge of interest in gene editing. The field has attracted the attention of big industry leaders such as Pfizer, Roche and Allergan, and has even received financial backing from the tech giant Amazon [1]. The upward trend in gene editing investments underpins the paramount importance of gene editing in numerous fields, especially science, medicine and agriculture.

IN SCIENCE

Gene editing tools enable scientists to study gene function and regulation more precisely, which could advance the field of biology and aid the understanding of diseases and developmental processes via generating cellular and animal models and functional genomic screens [2]. It could be used to recreate and study genetic changes for evolutionary studies, shedding light on how organisms have adapted and diversified over time.

IN MEDICINE

Gene editing produces one of the most tangible results in this field. It offers the possibility of correcting life-threatening genetic mutations that give rise to the various genetic disorders we see today. This can range from cystic fibrosis to sickle cell anaemia, and even muscular dystrophy [3]. Aside from genetic disorders, gene editing paves the way for novel therapeutics that include precise cancer therapies, immunotherapies, and personalised medicine.

IN AGRICULTURE, FOOD AND NUTRITION

Amidst the global food shortages caused by climate change, gene editing can be used to create crops that are more resistant to pests, diseases and environmental stresses like high temperatures [4]. It could also be used to enhance disease resistance in livestock, which increases animal welfare and reduces the need for antibiotics [5]. With hardier crops and livestock, both plant and animal agricultural productivity can be improved to address global food security challenges.

Gene Editing Techniques

The discovery of RNA-programmable CRISPR systems has led to the development of three classes of gene editing technologies - Cas nucleases, base editors, and prime editors. They can edit the genome across a wide range of target sites and in various cell types and organisms.

CAS NUCLEASES (CRISPR)

CRISPR utilizes a Cas9 nuclease to induce double stranded breaks (DSBs), which can be repaired via several cellular pathways to create a mix of insertion and deletion outcomes (indels). This process is not entirely specific as the formation of DSBs can cause large deletions and chromosomal translocations in the genome [6, 7]. It can also activate p53, possibly enriching oncogenic cells and increasing the risk of cancer [8].

BASE EDITING

Base editing allows for the creation of target point mutations without the need for DSBs [9]. It utilizes a Cas nuclease fused to a deaminase enzyme to chemically convert one base to another. However, its inability to introduce indels and transversions also hinder gene editing efforts. Its potential to similarly induce off-target mutations further limits its application in the real world [10].

PRIME EDITING

Prime editing utilizes a prime editor (PE), a fusion protein consisting of nCas9 (H840A) and an engineered Moloney Murine Leukemia Virus reverse transcriptase (MMLV-RT), and a prime editing guide RNA (pegRNA). It can also use a nicking guide RNA (ngRNA) to make it more precise. Unlike CRISPR, prime editing introduces single stranded nicks, which improves its precision and significantly reduces the possibility of off-target edits. It is also more versatile than base editing as it can introduce a wider variety of edits into the genome.

HOW PRIME EDITING WORKS

Figure 1.Graphical depiction of prime editing [11]

To initiate prime editing, the pegRNA binds to the DNA sequence of interest. The PE then creates a single-strand break in the DNA at the target site to allow MMLV-RT to access the DNA (Figure 1, Step 1). Subsequently, MMLV-RT synthesises a new DNA strand using pegRNA as a template (Figure 1, Steps 2-3). The information from the edited strand is thus copied to the complementary strand through the cell’s natural repair pathways (Figure 1, Steps 4-5).

Limitations of Prime Editing

Prime editing offers high efficiency, versatility and target specificity. Its broad editing spectrum potentially allows the correction of up to 89% of human genetic diseases [12]. While it has been demonstrated to work well in mammalian cells, the components necessary for it still require optimization [13].

Out of the three main components of the PE (Cas9, RT, pegRNA), the one that has seen the least variability on is the RT. Despite extensive research on prime editing, most researchers continue to use the MMLV-RT due to its versatility [14]. However, it has several limitations that negatively affect the prime editing efficiency, such as the type and length of the edit, the GC content of the extension sequence, and the target sites [15].

Moreover, as a relatively newer gene editing technique, there are no well-established reporter systems to test prime editing in various organisms. Most researchers directly test their PEs on endogenous sites such as HEK3 in mammalian cells. However, this is a time-consuming process as transfection of these plasmids can take around three days. This calls for the development of a quick and efficient reporter system to screen new PE constructs prior to endogenous site testing.

Our End Goal

We recognize that there is scope for further optimization by changing the reverse transcriptase (RT) component. By developing alternative RTs, we aim to match (or possibly improve) the prime editing efficiency in mammalian cells. In addition, we hope to develop a quick and accurate reporter system as a part collection for initial-stage screening of various PEs. By further extension, we seek to develop and demonstrate that prime editing can be used to edit the genomes of stem cells and chassis such as bacteria or yeast. Precise genome editing with the PE will allow for sophisticated engineering of these organisms for therapeutically or industrially relevant applications

WANT TO KNOW MORE?

REFERENCES

1. Smruthi Suryaprakash, S.B., Wen Xie, Michael Choy. Gene Editing Gets Ready for the Spotlight. 2022; Available from: https://www.bcg.com/publications/2022/gene-editing-ready-for-spotlight.

2. Li, H., et al., Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects. Signal Transduction and Targeted Therapy, 2020. 5(1): p. 1.

3. Genetic Alliance, D.o.C.D.o.H., Single-Gene Disorders, in Understanding Genetics: A District of Columbia Guide for Patients and Health Professionals. 2010, Genetic Alliance: Washington (DC).

4. Karavolias, N.G., et al., Application of Gene Editing for Climate Change in Agriculture. Frontiers in Sustainable Food Systems, 2021. 5.

5. Wang, S., et al., Application of Gene Editing Technology in Resistance Breeding of Livestock. Life (Basel), 2022. 12(7).

6. Cannan, W.J. and D.S. Pederson, Mechanisms and Consequences of Double-Strand DNA Break Formation in Chromatin. J Cell Physiol, 2016. 231(1): p. 3-14.

7. Kosicki, M., K. Tomberg, and A. Bradley, Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements. Nat Biotechnol, 2018. 36(8): p. 765-771.

8. Enache, O.M., et al., Cas9 activates the p53 pathway and selects for p53-inactivating mutations. Nat Genet, 2020. 52(7): p. 662-668.

9. Gaudelli, N.M., et al., Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage. Nature, 2017. 551(7681): p. 464-471.

10. Grünewald, J., et al., Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors. Nature, 2019. 569(7756): p. 433-437.

11. Zhao, Z., et al., Prime editing: advances and therapeutic applications. Trends in Biotechnology, 2023. 41(8): p. 1000-1012.

12. Arezi, B. and H. Hogrefe, Novel mutations in Moloney Murine Leukemia Virus reverse transcriptase increase thermostability through tighter binding to template-primer. Nucleic Acids Res, 2009. 37(2): p. 473-81.

13. Scholefield, J. and P.T. Harrison, Prime editing – an update on the field. Gene Therapy, 2021. 28(7): p. 396-401.

14. Oscorbin, I.P. and M.L. Filipenko, M-MuLV reverse transcriptase: Selected properties and improved mutants. Computational and Structural Biotechnology Journal, 2021. 19: p. 6315-6327.

15. Mathis, N., et al., Predicting prime editing efficiency and product purity by deep learning. Nat Biotechnol, 2023. 41(8): p. 1151-1159.